PharmaBoardroom

Interview with The Honourable Greg Combet, MP, Minister for…

Would you outline the commitment of the Ministry to foster a positive business environment for the Australian pharmaceutical industry to prosper?…

Interview with Francis Lynch, General Manager, A Menarini Ireland…

You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market…

Interview with The Honourable Mark Butler, MP, Minister for…

You were appointed last year with a specialized portfolio reflecting some of the key priorities on the country’s health care agenda. Would you begin…

Interview with Zhang Zegong, Deputy Director-General, BPBC

From out meeting with BPBC in 2009, we know that your slogan is to “grow up with industry.” How have you grown up since then? Firstly, I’d…

Interview with Mark Connolly, Managing Director Benelux,…

Can you illustrate to our readers the company’s main milestones and key achievements since you took the reins four years ago? In the last years we…

Interview with Mark Fladrich, Managing Director, Australia &…

You returned to Australia a year ago after spending eight years in Europe with the company. In your view, what were the key changes in the Australian…

Interview with Patrick Bergstedt, President, Asia Pacific, MSD

In Q3 2012, MSD reported worldwide sales of $11.5 billion. What was the contribution that emerging markets had? From an MSD perspective, emerging…

Interview with Guido Hoogewijs, General Manager, The Belgian…

Let us begin by getting an overview of APB’s functions & objectives and your role within the association as General Manager? The Belgian…

Interview with Christina Teo, Country Manager, Pfizer

Pfizer completed the acquisition of Wyeth three years ago. How did the merge impact the Singaporean operations? As the result of the merge, Pfizer…

Interview with Takeshi Yura, Senior Director, Albany Molecular…

Prior to joining AMRI you worked in diverse companies in Japan, like Dishman, Pfizer and Bayer. What attracted you to this company? The main reason…

Interview with Eduardo Bravo, CEO, TiGenix – Belgium

Mr Bravo, in relation to your previous career in big pharma companies, you have recently made a shift into much smaller entities including Cellerix…

Interview with Fabrice Claisse, , Novo Nordisk – Belgium

Looking into your background, we see that you have developed your career in the local industry’s top 3 players: Pfizer, AstraZeneca and Novartis…

Tagged with